Bayer Aktiengesellschaft (VIE:BAYN)
Austria · Delayed Price · Currency is EUR | Market Cap | 37.67B +92.7% |
| Revenue (ttm) | 45.58B -2.2% |
| Net Income | -3.62B |
| EPS | -3.68 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 9.04 |
| Dividend | 0.11 (0.27%) |
| Ex-Dividend Date | Apr 27, 2026 |
| Volume | 560 |
| Average Volume | 765 |
| Open | 38.56 |
| Previous Close | 38.44 |
| Day's Range | 38.15 - 38.56 |
| 52-Week Range | 22.19 - 49.70 |
| Beta | n/a |
| RSI | 39.64 |
| Earnings Date | May 12, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge... [Read more]
Financial Performance
In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.
Financial StatementsNews
Bayer Faces Supreme Court Hearing on Roundup Liability
Bayer Faces Supreme Court Hearing on Roundup Liability
US Supreme Court hears Bayer's fight against Roundup lawsuits
The U.S. Supreme Court is set on Monday to consider Bayer AG's effort to shut down thousands of lawsuits accusing the company of failing to warn users that the active ingredient in its Roundup weedki...
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Bayer (BAYRY) Faces Supreme Court Hearings on Roundup Lawsuits
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
The U.S. Supreme Court hears arguments on Monday in Bayer's bid to limit thousands of lawsuits alleging that the German company's Roundup weedkiller causes cancer in a case that is one part of sprawli...
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Bayer Advances $7.25 Billion Roundup Settlement Ahead of Key Supreme Court Ruling
Buy or Goodbye?: Alphabet, Nestle, Bayer und SAP - Die Analystenstimmen des Tages
Alphabet, Nestle, Bayer und SAP: Die wichtigsten Analysten-Updates im Überblick.
Bayer Aktiengesellschaft Transcript: AGM 2026
The meeting highlighted strong operational progress, debt reduction, and a continued focus on litigation containment and innovation. Shareholders approved all management proposals, including a minimum dividend, while voicing concerns on governance, product safety, and environmental impact.
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
Bayer (BAYRY) Faces Crucial $7.5 Billion Settlement Decision in Roundup Litigation
The Cancer Victims Who Could Sink Bayer's Roundup Settlement
With thousands of cases piling up in U.S. courts, the company's relief plans still face hurdles.
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in hal...
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
Bayer's Lawsuit Against Johnson & Johnson Over Prostate Cancer Drug Advertising Dismissed
U.S. judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer’s request for an injunction to block Johnson & Johnson’s alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in half...
U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
A federal judge rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer i...
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bayer Canada is proud to support the Simon Fraser University (SFU) School of Medicine - the first medical school in Western Canada in nearly 60 years. The new sc...
Bayer US head says tariffs will not affect its 2026 forecasts
A top Bayer AG executive said on Tuesday the German drugmaking and crop science company saw no need to adjust its 2026 forecasts because of tariffs on imported pharmaceuticals announced by the U.S. ...
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regim...
Bayer Weighs U.S. Pharma Expansion as Turnaround Picks Up Speed
How Bayer Uses AI to Avoid Sending Customers to its Competition
As generative AI and creators take a bigger hand in producing creative work, brand managers face a crucial question: Who’s watching to ensure its all working together to build brand […]
National Advertising Division Recommends Bayer Modify or Discontinue Certain One A Day Men's Pre-Conception Health Complete Multivitamin Claims
Following a challenge brought by OLLY PBC, BBB National Programs' National Advertising Division recommended that Bayer HealthCare LLC discontinue or modify certain claims for its One A Day® Men's Pre-...
Bayer Announces Leadership Change Within Pharmaceuticals' Worldwide Markets Organization in the U.S. to Support Company's Full Growth Potential
Nelson Ambrogio appointed to lead U.S. pharmaceuticals business, Bayer's largest pharmaceutical growth market Appointment supports Bayer Pharmaceuticals' strategy to renew top-line growth and maxi...
Bayer Announces Leadership Change Within Pharmaceuticals' Worldwide Markets Organization in the U.S. to Support Company's Full Growth Potential
BERLIN--(BUSINESS WIRE)--Bayer today announced a leadership change within its Pharmaceuticals' Worldwide Markets organization to accelerate the strong performance and growth of its key pharmaceutical ...
Bayer Announces Approval Of New Indication For Kerendia In The EU
(RTTNews) - Bayer (BYR.L, BAYRY.PK, BAYZF.PK, BAY.MI, BAYN.DE) announced that the European Commission has granted approval in the European Union for Kerendia or finerenone, a selective, non-steroidal ...
EQS-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Bayer Aktiengesellschaft Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Euro...
Bayer Crop Science Canada Redefines Canola Innovation With New "Advancing Better Canola" Initiative
CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in sup...
Activist investor Inclusive Capital looks to sell stake in Bayer, Bloomberg News reports
Inclusive Capital Partners is looking to sell a stake in German agriculture and health firm Bayer AG , Bloomberg News reported on Monday.